Revenue Expectations - The company expects a revenue of between 245 million to 265 million CNY for the first half of 2024, compared to 153.37 million CNY in the same period last year, indicating a significant growth[4]. - The increase in revenue is attributed to the profitability of the medical information and services business, despite losses in the photovoltaic sector due to declining product prices[7]. Profit Projections - The net profit attributable to the parent company is projected to be between -50 million to -75 million CNY for the first half of 2024, compared to -57.79 million CNY in the same period last year, indicating continued losses[4]. - The net profit attributable to the parent company, after deducting non-recurring gains and losses, is expected to be between -120 million to -165 million CNY for the first half of 2024[4]. - The company reported a total profit of -49.53 million CNY and a net profit of -57.79 million CNY for the first half of 2023[6]. Financial Forecast Reliability - The company emphasizes that there are no significant uncertainties that could affect the accuracy of this earnings forecast[8]. - The preliminary financial data provided is subject to final confirmation in the official half-year report[9].
麦迪科技(603990) - 2024 Q2 - 季度业绩预告